Effect of pyrimethamine in experimental rheumatoid arthritis

Medical Science Monitor

Volumn 11, Issue 8, 2005, Pages

  Saadat, Farshid ^a   Cuzzocrea, Salvatore ^b   Di Paola, Rosanna ^b   Pezeshki, Mohammad ^a   Khorramizadeh, Mohammad Reza ^a   Sedaghat, Reza ^c   Razavi, Alireza ^a   Mirshafley, Abbas ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF MESSINA   (Italy)

^c SHAHED UNIVERSITY   (Iran)

Author keywords

Antimalarial drugs; Nitric oxide; Pyrimethamine; Rheumatoid arthritis

Indexed keywords

ANTIMALARIAL AGENT; METHOTREXATE; NITRIC OXIDE; PYRIMETHAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BIOCOMPATIBILITY; BONE EROSION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; NONHUMAN; RAT; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS;

ANIMALS; ANTIBODIES; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELL LINE; CELL SURVIVAL; MALE; MATRIX METALLOPROTEINASE 2; MICE; NITRIC OXIDE; PYRIMETHAMINE; RATS; RATS, INBRED LEW;

EID: 24044471630     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Harris ED Jr: Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med, 1990; 322: 1277-89
2. Griffiths MM, Eichwald EJ, Martin JH et al: Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arthritis Rheum, 1981; 24: 781-89
3. Larsson P, Kleinau S, Holmdahl R, Klareskog L: Homologous type II collagen-induced arthritis in rats: characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation. Arthritis Rheum, 1990; 33: 693-701
4. Stuart JM, Townes AS, Ang AH: The role of collagen autoimmunity in animals and human diseases. J Invest Dermatol, 1982; 79(Suppl.) : 1-11
5. Cathcart ES, Hayes KC, Gonnerman WA et al: Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen. Lab Invest, 1986; 54: 26-31
6. Clague RB, Morgan K, Shaw MJ, Holt PJ: Native type II collagen-induced arthritis in the rat. II. Relationship between the humoral immune response to native type II collagen and arthritis. J Rheumatol, 1980; 7: 775-82
7. Takeshita M, Hinoue H, Furukawa O, Takata I: Initial arthritic lesions induced by immunization with type II collagen in Lewis rats. Exp Anim, 1995; 44: 63-66
8. Takeshita M, Sugita T, Takata I: Pathological evaluation of effect of anti-rheumatic drugs on type II collagen-induced arthritis in Lewis rats. Exp Anim, 1997; 46: 165-69
9. Holmdahl R, Andersson M, Goldschmidt TJ et al: Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev, 1990; 118: 193-232
10. van der Heijde DM: Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol, 1995; 34(Suppl.2): 74-78
11. Weinblatt ME: Rheumatoid arthritis: treat now, not later. Ann Intern Med, 1996; 124: 773-74
12. Boey ML: Treatment strategies in rheumatoid arthritis. Singapore Med J, 1992; 33: 631-32
13. Baggott JE, Morgan SL, Ha T et al: Inhibition of folate-dependent enzymes by non-steroidal anti-inflammatory drugs. Biochem J, 1992; 282: 197-202
14. Andersson SE, Johansson LH, Lexmuller K, Ekstrom GM: Anti-arthritic effect of methotrexate: is it really mediated by adenosine? Eur J Pharm Sci, 2000; 9: 333-43
15. Hornung N, Stengaard-Pedersen K, Ehrnrooth E et al: The effects of low-dose methotrexate on thymidylate synthetase activity in human peripheral blood mononuclear cells. Clin Exp Rheumatol, 2000; 18: 691-88
16. de Lathouder S, Gerards AH, Dijkmans BA, Aarden LA: Two inhibitors of DNA-synthesis lead to inhibition of cytokine production via a different mechanism. Nucleosides Nucleotides Nucleic Acids, 2004; 23: 1089-100
17. Schurmann D, Bergmann F, Albrecht H et al: Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS. J Infect, 2001; 42: 8-15
18. Hyde JE: The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites. Pharmacol Ther, 1990; 48: 45-59
19. Hunt SY, Rezvani BB, Sibley CH: Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil. Mol Biochem Parasitol, 2005; 139: 25-32
20. Cuzzocrea S, Mazzon E, Bevilaqua C et al: Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats. Br J Pharmacol, 2000; 131: 1399-407
21. Szabo' C, Virag L, Cuzzocrea S et al: Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthetase. Proc Natl Acad Sci USA, 1998; 9: 3867-72
22. Bremell T, Abdelnour A, Tarkowski A: Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun, 1992; 60: 2976-85
23. Oliver SJ, Cheng TP, Banquerigo ML, Brahn E: Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF). Cell Immunol, 1995; 166: 196-206
24. Mirshafiey A, Chitsaz M, Attar M et al: Culture filtrate of Cryptococcus neoformans var. gattii (CneF) as a novel anti-inflammatory compound in the treatment of experimental septic arthritis. Scand J Immunol, 2000; 52: 278-84
25. Cuzzocrea S, Costantino G, Mazzon E, Caputi AP: Beneficial effects of raxofelast (IRFI 016), a new hydrophilic vitamin E-like antioxidant, in carrageenan-induced pleurisy. Br J Pharmacol, 1999; 126: 407-14
26. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activator in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Analytical Biochemistry, 1980; 102: 196-202
27. Finesilver AG: Newer approaches to the treatment of rheumatoid arthritis. WMJ, 2003; 102: 34-37
28. Araiza-Casillas R, Cardenas F et al: Factors associated with chloroquine-induced retinopathy in rheumatic diseases. Lupus, 2004; 13: 119-24
29. Wassenberg S, Rau R: Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis. J Rheumatol, 2003; 1891: 1891-92
30. Johnsen V, Forre O, Haga HJ et al: Combination therapy in rheumatoid arthritis. Tidsskr Nor Laegeforen, 2003; 123: 1511-13
31. Carmichael SJ, Charles B, Tett SE: Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis. Ther Drug Monit, 2003; 25: 671-61
32. Carmichael SJ, Beal J, Day RO, Tett SE: Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate. J Rheumatol, 2002; 32: 2077-83
33. Ruf B, Schurmann D, Bergmann F et al: Efficacy of pyrimethamine/ sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients. Eur J Clin Microbiol Infect Dis, 1993; 12: 325-29
34. Opravil M, Pechere M, Lazzarin A et al: Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus. Clin Infect Dis, 1995; 20: 244-49
35. Ialenti A, Moncada S, Di Rosa M: Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol, 1993; 110: 701-6
36. Salvemini D, Wang ZQ, Wyatt PS et al: Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br J Pharmacol, 1996; 118: 829-38
37. Terato K, Hasty KA, Reife RA et al: Induction of arthritis with monoclonal antibodies to collagen. J Immunol, 1992; 148: 2103-8
38. Mattsson L, Lorentzen JC, Svelander L et al: Immunization with Alum-Collagen II complex suppresses the development of collagen-induced arthritis in rats by deviating the immune response. Scand J Immunol, 1997; 46: 619-24
39. Hitchon CA, Danning CL, Illei GG et al: Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis. J Rheumatol, 2002; 29: 107-17
40. Jackson CJ, Arkell J, Nguyen M: Rheumatoid synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP (TIMP1). Ann Rheum Dis, 1998; 57: 158-61
41. Espevik T, Nissen-Meyer J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods, 1986; 95: 99-105
42. Firestein GS: Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors? Arthritis Rheum, 1996; 39: 1781-90
43. Bucala R, Ritchlin C, Winchester R, Cerami A: Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med, 1991; 173: 569-74
44. Cho ML, Kim WU, Min SY et al: Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor α production by rheumatoid synoviocytes. Arthritis Rheum, 2002; 46: 42-51